Description of the Business

For a description of the business see: About ReNeuron


Directors and Committees

For information about the board see: Board of Directors

For information about the responsibilities of the directors and any committees see: Corporate Governance


Country of Incorporation and Main Country of Operation

For details of ReNeuron’s country of incorporation and main country of operation see: About ReNeuron


Current Constitution Documents

To view current constitution documents see: Documents and Circulars


Securities in Issue

For information about number of securities in issue and the percentage of AIM securities not in public hands, together with the identity and percentage of significant shareholders see: Major Shareholdings

The Company is not listed on any other exchanges or trading platforms.

There are no restrictions on the transfer of the Company’s securities.

The Company is subject to the UK City Code on Takeovers and Mergers.

Financial Reports

For the most recent annual and interim reports see: Financial Reports


Company Announcements

To see recent and historic regulatory announcements see: RNS Announcements


Admission Documents

For ReNeuron’s Admission Document see: Documents and Circulars



To see details of the Company’s advisors see: Advisors


This section of the website, and the information that can be accessed from this page, was last updated to comply with Rule 26 on: 18 March 2019